Failure_of_dithiothreitol_and_pronase_to_reveal_a_false-positive_cryptococcal_antigen_determination_in_cerebrospinal_fluid._A_patient_with_squamous_cell_carcinoma_of_the_lung_and_a_serum_rheumatoid_factor_(RF)_of_1:1,280_had_a_positive_cerebrospinal_fluid_(CSF)_latex_agglutination_test_(LAT)_for_cryptococcal_antigen,_in_culture-negative,_India-ink-negative_CSF._Pretreatment_of_the_sample_of_CSF_with_2-mercaptoethanol_(2-ME)_ablated_the_antigen_titer_and_established_the_presence_of_a_false-positive_LAT,_whereas_CSF_pretreated_with_dithiothreitol_(DTT)_and_pronase_continued_to_yield_a_false-positive_result._The_differing_ability_of_pronase,_DTT,_and_2-ME_to_eliminate_interfering_substances_from_CSF_has_not_been_previously_described._Moreover,_because_RF_is_unlikely_to_cross_the_blood-brain_barrier,_the_authors_postulated_that_malignant_disease_was_responsible_for_the_patient's_false-positive_LAT_in_CSF._Hence,_the_authors_report_the_case_to_emphasize_that_false-positive_LAT_results_in_CSF_are_unlikely_to_be_produced_by_RF_and_to_underscore_the_benefit_of_using_enzymatic_and_sulfhydryl-reducing_agents_when_the_validity_of_the_initial_test_results_are_in_doubt._Such_a_procedure_will_optimize_the_chances_of_accurately_identifying_false-positive_LAT_results_in_CSF.